The cellular activity of different sized follicles in cycles treated with gonadotrophin-releasing hormone analogue.

By Andreani C L   Diotallevi L   Lazzarin N   Pierro E   Giannini P   Lanzone A   Capitanio P   Mancuso S  

Human Reproduction, Vol. 12, Iss. 1, 1997-01 ,pp. : 89-94

Oxford University Press

Access to resources Recommend Favorite

Induction of the endogenous gonadotrophin surge for oocyte maturation with intra-nasal gonadotrophin-releasing hormone analogue (buserelin): effective minimal dose

By Buckett WM  

Human Reproduction, Vol. 13, Iss. 4, 1998-04 ,pp. : 811-814

Oxford University Press

Access to resources Recommend Favorite

Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist?

By Lin Y  

Human Reproduction, Vol. 14, Iss. 4, 1999-04 ,pp. : 885-888

Oxford University Press

Access to resources Recommend Favorite

Health-related quality of life following surgical menopause and following gonadotrophin-releasing hormone analogue-induced pseudomenopause

By Bhattacharya Sudhindra Mohan  

Gynecological Endocrinology, Vol. 25, Iss. 9, 2009-09 ,pp. : 621-623

Informa Healthcare

Access to resources Recommend Favorite

Specific gonadotrophin-releasing hormone analogue binding predominantly in human luteinized follicular aspirates and not in human pre-ovulatory follicles.

By Brus L   Lambalk C B   de Koning J   Helder M N   Janssens R M   Schoemaker J  

Human Reproduction, Vol. 12, Iss. 4, 1997-04 ,pp. : 769-773

Oxford University Press

Access to resources Recommend Favorite